AVITA Medical (AVHHL) Other financing activities (2021)

AVITA Medical (AVHHL) reported Other financing activities of $5.1 million for Q3 2021, little changed quarter-over-quarter from $5.1 million in Q1 2021.

AVITA Medical (AVHHL) Other financing activities (2021) Analysis & Trends

AVITA Medical has reported Other financing activities for 1 years, with the latest figure at $5.1 million in Q3 2021.

  • For the quarter ending Q3 2021, Other financing activities changed N/A year-over-year to $5.1 million; the trailing twelve-month figure through Sep 2021 stood at $10.2 million (changed N/A YoY), and the FY2021 full-year result was $5.1 million, up 0.63% from the prior year.
  • Other financing activities for Q3 2021 stood at $5.1 million, roughly flat from $5.1 million in the prior quarter.
  • The five-year high for Other financing activities was $5.1 million in Q1 2021, with the low at $5.1 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 AVITA Medical - - 14.31 Mn

Historic Data

Download Data
DateValue
Sep 30, 2021 5.11 Mn
Sep 30, 2021 5.11 Mn
Mar 31, 2021 5.11 Mn
Mar 31, 2021 5.11 Mn